Suzan van Amerongen1,2,3, Dewi K Caton1,3, Yolande A L Pijnenburg1,2, Philip Scheltens1,2, Everard G B Vijverberg1,2,3. 1. Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands. 2. Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands. 3. Brain Research Center, Amsterdam, The Netherlands.
Abstract
Introduction: Traumatic brain injury (TBI) has been associated with a greater risk of developing Alzheimer's disease (AD). Less is known about the clinical features of AD patients with TBI history. The objective of this study was to examine whether a history of TBI and specific injury characteristics are associated with differences in age of disease onset, cognitive features, and neuropsychiatric symptoms (NPSs) in AD patients. Methods: Biomarker-proven AD patients (CSF or amyloid PET) were selected from the Amsterdam Dementia Cohort. TBI events were classified by age at injury (TBI <25 or ≥25 years) and TBI severity (loss of consciousness, multiple events). Cognitive composite scores were calculated from results of a neuropsychological test battery. NPSs were assessed with the Neuropsychiatric Inventory Questionnaire (NPI-Q). Linear regression analyses were utilized to examine associations between TBI, TBI characteristics, and clinical outcome measures. Results: Among the 1,755 selected AD patients (mean age = 65.2 years), 166 (9.5%) had documented ≥1 TBI in their medical history. Overall, TBI history was not related to differences in age of disease onset, but age at injury <25 years old was associated with 2.3 years earlier age at symptom onset (B = -2.34, p = 0.031). No significant associations were found between TBI history or TBI characteristics and differences in cognition or NPSs. Conclusion: Our results underscore previous findings on the vulnerability of the brain during critical maturation phases and suggest that an early TBI may contribute to lower resilience to neurodegenerative changes.
Introduction: Traumatic brain injury (TBI) has been associated with a greater risk of developing Alzheimer's disease (AD). Less is known about the clinical features of AD patients with TBI history. The objective of this study was to examine whether a history of TBI and specific injury characteristics are associated with differences in age of disease onset, cognitive features, and neuropsychiatric symptoms (NPSs) in AD patients. Methods: Biomarker-proven AD patients (CSF or amyloid PET) were selected from the Amsterdam Dementia Cohort. TBI events were classified by age at injury (TBI <25 or ≥25 years) and TBI severity (loss of consciousness, multiple events). Cognitive composite scores were calculated from results of a neuropsychological test battery. NPSs were assessed with the Neuropsychiatric Inventory Questionnaire (NPI-Q). Linear regression analyses were utilized to examine associations between TBI, TBI characteristics, and clinical outcome measures. Results: Among the 1,755 selected AD patients (mean age = 65.2 years), 166 (9.5%) had documented ≥1 TBI in their medical history. Overall, TBI history was not related to differences in age of disease onset, but age at injury <25 years old was associated with 2.3 years earlier age at symptom onset (B = -2.34, p = 0.031). No significant associations were found between TBI history or TBI characteristics and differences in cognition or NPSs. Conclusion: Our results underscore previous findings on the vulnerability of the brain during critical maturation phases and suggest that an early TBI may contribute to lower resilience to neurodegenerative changes.
Authors: S M Rosso; E-J Landweer; M Houterman; L Donker Kaat; C M van Duijn; J C van Swieten Journal: J Neurol Neurosurg Psychiatry Date: 2003-11 Impact factor: 10.154
Authors: Julie M Stamm; Alexandra P Bourlas; Christine M Baugh; Nathan G Fritts; Daniel H Daneshvar; Brett M Martin; Michael D McClean; Yorghos Tripodis; Robert A Stern Journal: Neurology Date: 2015-01-28 Impact factor: 9.910
Authors: Z Guo; L A Cupples; A Kurz; S H Auerbach; L Volicer; H Chui; R C Green; A D Sadovnick; R Duara; C DeCarli; K Johnson; R C Go; J H Growdon; J L Haines; W A Kukull; L A Farrer Journal: Neurology Date: 2000-03-28 Impact factor: 9.910
Authors: L Fratiglioni; L J Launer; K Andersen; M M Breteler; J R Copeland; J F Dartigues; A Lobo; J Martinez-Lage; H Soininen; A Hofman Journal: Neurology Date: 2000 Impact factor: 9.910
Authors: Wiesje M van der Flier; Yolande A L Pijnenburg; Niels Prins; Afina W Lemstra; Femke H Bouwman; Charlotte E Teunissen; Bart N M van Berckel; Cornelis J Stam; Frederik Barkhof; Pieter Jelle Visser; Evan van Egmond; Philip Scheltens Journal: J Alzheimers Dis Date: 2014 Impact factor: 4.472
Authors: Michael A Sugarman; Ann C McKee; Thor D Stein; Yorghos Tripodis; Lilah M Besser; Brett Martin; Joseph N Palmisano; Eric G Steinberg; Maureen K O'Connor; Rhoda Au; Michael McClean; Ronald Killiany; Jesse Mez; Michael W Weiner; Neil W Kowall; Robert A Stern; Michael L Alosco Journal: Alzheimers Dement Date: 2019-03-07 Impact factor: 21.566
Authors: J A Mortimer; C M van Duijn; V Chandra; L Fratiglioni; A B Graves; A Heyman; A F Jorm; E Kokmen; K Kondo; W A Rocca Journal: Int J Epidemiol Date: 1991 Impact factor: 7.196